The Power of CBT-I for Anxiety and Insomnia: Treating Both at Once

Anxiety and insomnia don't just co-occur — they fuel each other. CBT-I breaks both cycles simultaneously.

By Eleanor Hayes·January 25, 2026·9 min read·Reviewed by Dr. Alyssa Park, PhD, Behavioral Sleep Medicine

The Power of CBT-I for Anxiety and Insomnia: Treating Both at Once — Photograph for Sleep Editorial.

Anxiety and insomnia are not merely co-occurring conditions that happen to affect the same people. They are neurologically intertwined disorders with bidirectional relationships: anxiety causes and worsens insomnia, and insomnia causes and worsens anxiety. This relationship is not incidental — it reflects shared neurobiological mechanisms involving the amygdala, the HPA axis, and the prefrontal cortex that regulate both threat detection and sleep-wake transitions.

For people navigating both anxiety and insomnia, this interdependence is often experienced as a frustrating trap: poor sleep worsens anxiety, which worsens sleep, which worsens anxiety. Understanding how CBT-I addresses this loop — and why targeting the sleep side of the bidirectional relationship often produces improvements in both conditions simultaneously — offers a way out of the trap that medication alone cannot provide.

The Neuroscience of Anxiety-Driven Insomnia

Anxiety activates the amygdala, which triggers the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic nervous system — the threat-detection and stress-response systems. These systems release cortisol and catecholamines (epinephrine and norepinephrine) that increase alertness, raise core body temperature, elevate heart rate, and maintain prefrontal cortex activation. All of these physiological changes directly oppose the neurological conditions required for sleep onset: falling body temperature, slowing heart rate, quieting prefrontal cortex activity.

Sleep requires the brain to relinquish active monitoring and threat vigilance. For an anxious brain, this relinquishment is precisely what anxiety prevents. The result is a person who is exhausted but cannot stop the activation cycle long enough to allow sleep. The harder they try — the more they monitor for sleep, the more they catastrophize about not sleeping — the more activation they generate, and the further sleep recedes.

The relationship runs in the other direction too. Poor sleep impairs amygdala regulation by the prefrontal cortex. The prefrontal cortex normally modulates the amygdala's reactivity — applying cognitive brakes to emotional responses. Sleep deprivation degrades this regulatory capacity, leaving the amygdala more reactive to neutral stimuli and generating elevated anxiety responses that would not occur with adequate sleep. This prefrontal-amygdala relationship is one of the most robustly replicated findings in sleep-emotion neuroscience research.

Why Standard Anxiety Treatment Often Fails to Resolve Insomnia

People who seek treatment for anxiety but not specifically for insomnia often expect their sleep to improve as anxiety is treated. In some cases this is true, particularly for acute anxiety responses. For chronic insomnia with comorbid anxiety, however, the expectation frequently does not match the outcome. Even as anxiety is meaningfully reduced through CBT for anxiety, SSRI pharmacotherapy, or other interventions, the insomnia may persist.

This persistence reflects the maintaining factors of insomnia that are independent of the current anxiety level. Conditioned arousal — the learned association between bed and wakefulness — does not dissolve when anxiety decreases. Excessive time in bed — maintained by compensatory behavior during the anxious insomnia period — continues to reduce homeostatic sleep pressure regardless of anxiety treatment. Maladaptive sleep-specific beliefs ("I can't sleep without medication," "I need eight hours or I won't function") continue to generate performance anxiety at bedtime regardless of whether general anxiety has improved.

These maintaining factors require targeted intervention — specifically, the behavioral prescriptions of CBT-I — to resolve. Treating anxiety without addressing the sleep-specific maintaining factors leaves the insomnia intact. This is why the clinical recommendation for comorbid anxiety and insomnia is increasingly to treat both conditions concurrently rather than sequentially.

How CBT-I Addresses Anxiety-Driven Insomnia

CBT-I is particularly well-matched to anxiety-driven insomnia because its components directly target both the sleep-specific and anxiety-related mechanisms.

Stimulus Control: Breaking the Conditioned Fear of Bedtime

For people with anxiety-driven insomnia, bedtime is associated not merely with wakefulness but with dread — a conditioned emotional response that triggers full-scale anxiety activation the moment sleep is attempted. Stimulus control extinguishes this conditioned response by systematically ensuring that the bed is associated only with sleep. Every night spent leaving the bed when awake and returning only when drowsy is a reconditioning trial that gradually shifts the conditioned response from anxiety to drowsiness.

This process is analogous to exposure therapy for phobias — the primary evidence-based treatment for anxiety disorders. Exposure therapy works by repeatedly presenting the feared stimulus without the feared consequence, extinguishing the conditioned fear response. Stimulus control applies the same principle to the bedtime context: repeated association of the bed with drowsy, comfortable sleep — rather than anxious wakefulness — extinguishes the conditioned fear that bedtime has acquired.

Sleep Restriction: Overcoming Sleep Performance Anxiety

Sleep performance anxiety — the specific anxiety about the process of falling asleep — is one of the most treatment-resistant aspects of anxiety-driven insomnia. The more the person monitors for sleep onset and evaluates their progress, the more aroused and therefore less sleepy they become. Sleep restriction addresses this by making the drive to sleep so strong that performance anxiety cannot sustain itself against it. When sleep pressure is high enough, sleep happens — not through force of will but through neurological necessity. Repeated experiences of sleep occurring naturally, without effortful monitoring, begin to break the performance anxiety cycle.

Cognitive Restructuring: The Shared Mechanism

Cognitive restructuring in CBT-I addresses the same cognitive distortions that CBT for anxiety targets in the general anxiety context: catastrophizing, overgeneralization, fortune-telling, and all-or-nothing thinking, applied specifically to sleep. "If I don't sleep tonight, tomorrow will be a catastrophe" is a textbook catastrophic cognition that generates the same cortisol response whether it appears in an anxiety-focused session or a sleep-focused one.

The cognitive tools applied in CBT-I for sleep-related cognitions — identifying the distortion, examining the evidence, generating a more balanced alternative — are directly transferable to and compatible with CBT for anxiety. For many patients, the sleep-focused cognitive work actively reduces general anxiety reactivity because it trains the cognitive flexibility that is the mechanism of CBT in all its forms.

Evidence for CBT-I in Comorbid Anxiety and Insomnia

The research on CBT-I specifically in populations with anxiety disorders is both substantial and consistently positive. Multiple randomized controlled trials have examined CBT-I in populations with generalized anxiety disorder, PTSD, panic disorder, and comorbid anxiety with insomnia. The consistent finding across studies is that CBT-I produces significant improvements in insomnia outcomes — sleep onset latency, wake after sleep onset, sleep efficiency, insomnia severity — in anxious populations, with effect sizes comparable to those seen in non-anxious insomnia populations.

Equally important is what these trials find for the anxiety outcomes. Multiple studies have documented that improvements in insomnia through CBT-I are associated with reductions in anxiety symptoms, including worry, daytime anxiety, and emotional reactivity. A 2019 meta-analysis in the Journal of Anxiety Disorders found that CBT-I in populations with comorbid anxiety produced significant improvements in both insomnia severity and anxiety symptom measures, with sleep improvements predicting subsequent anxiety reductions.

This bidirectional improvement — treating the insomnia improving the anxiety, not just the reverse — reflects the neurobiological interconnection between the two conditions. Improving sleep restores prefrontal regulation of the amygdala, reducing anxiety reactivity from the bottom up even as cognitive restructuring reduces it from the top down.

Practical Integration: Treating Both Conditions

For people with both anxiety and insomnia, the most effective treatment approach addresses both conditions explicitly rather than assuming one will resolve the other. CBT-I combined with CBT for anxiety, or CBT-I delivered within a broader cognitive behavioral framework that addresses both sleep and anxiety cognitions, produces better outcomes for both conditions than either alone in clinical practice.

Digital CBT-I programs have made this dual-condition approach more accessible. Programs that incorporate anxiety management components alongside the standard CBT-I protocol — addressing pre-sleep worry, the anxiety cascade at 3 a.m., and the role of daytime stress in nocturnal hyperarousal — provide a more comprehensive treatment than pure CBT-I for people whose insomnia is primarily anxiety-driven.

The order of treatment is less important than concurrent treatment. Some clinicians start with CBT-I, noting that improving sleep first may make the patient more cognitively capable and emotionally regulated for the anxiety work. Others start with anxiety management to reduce the baseline arousal level that CBT-I must then address. Both approaches are supported in the literature. The critical insight is that both conditions need specific attention — the assumption that treating one will automatically resolve the other is frequently incorrect.

Frequently Asked Questions

Does treating insomnia help reduce anxiety?

Yes. Multiple studies show that treating insomnia with CBT-I produces significant reductions in anxiety symptoms, not just sleep improvements. The mechanism reflects the bidirectional relationship: improving sleep restores prefrontal cortex regulation of the amygdala, reducing anxiety reactivity. Treating insomnia is therefore not just treating a sleep problem — it is addressing one of the primary biological drivers of anxiety dysregulation.

Should I treat my anxiety or my insomnia first?

The most effective approach is typically to treat both concurrently. Both conditions have specific maintaining factors that require targeted intervention — treating one will not reliably resolve the other. CBT-I addresses sleep-specific maintaining factors; CBT for anxiety or an equivalent approach addresses anxiety-specific factors. The two are complementary and can be conducted simultaneously or in a program that integrates both.

Can CBT-I make anxiety worse?

The initial weeks of CBT-I — particularly during sleep restriction — typically increase fatigue, and fatigue can temporarily worsen anxiety reactivity. This transient worsening is expected and resolves as sleep improves. Most people with anxiety-driven insomnia experience significant reduction in anxiety as sleep consolidates during weeks three to six of CBT-I. If anxiety worsens substantially and does not resolve, clinical evaluation by a mental health provider alongside the sleep program is appropriate.

What if my anxiety is too severe for CBT-I alone?

CBT-I is not a standalone treatment for severe anxiety disorders. For people with significant generalized anxiety, PTSD, panic disorder, or OCD, CBT-I addresses the sleep component of the presentation but not the full anxiety condition. Concurrent work with a mental health provider who addresses the anxiety using evidence-based approaches (CBT, EMDR for PTSD, medication management) alongside CBT-I for the sleep component is the recommended approach for complex comorbid presentations.

The Takeaway

Understanding the evidence and mechanisms behind effective insomnia treatment empowers people to make better decisions about their own care. The research is clear that behavioral treatment — specifically CBT-I — produces the most durable improvements in sleep outcomes for chronic insomnia, with a safety profile that pharmacological treatments cannot match. Accessing this treatment through in-person specialists, telehealth, or digital programs has never been more achievable. The most important next step is matching the treatment approach to the specific mechanisms driving the sleep problem — and then following through with the behavioral work that produces lasting change.

Whether you are at the beginning of investigating a sleep problem, midway through a treatment course, or managing long-standing insomnia that has resisted prior interventions, the core message of the evidence is consistent: the brain's capacity for restorative sleep is intact in most people with insomnia. What behavioral treatment does is remove the patterns that are blocking it — not create a new capacity, but restore one that was present all along. That restoration, for most people who complete a full course of evidence-based treatment, is achievable within weeks.

A Hardware Approach to Calming the Nervous System

Diaphragmatic breathing and progressive muscle relaxation work by activating the vagus nerve—the primary conduit of parasympathetic signaling that governs rest and recovery. For people who find breathwork alone insufficient, transcutaneous vagus nerve stimulation (tVNS) devices offer a more direct route to the same physiological effect. Pulsetto is a consumer tVNS device worn at the neck that delivers gentle electrical pulses to the cervical branch of the vagus nerve, measurably reducing heart rate, lowering cortisol, and shifting autonomic balance toward parasympathetic dominance. A growing body of research on cervical tVNS supports its use for stress reduction and sleep quality improvement, and Pulsetto carries no pharmacological side effects or addiction risk. It is a reasonable addition to a relaxation toolkit for people whose anxiety-driven arousal at bedtime has not responded adequately to breathwork or PMR alone.

Disclosure

Sleep Editorial is an independent publication. This article was reported and written without compensation from any product or service mentioned. Sleep Editorial does not provide medical advice; consult a qualified clinician for diagnosis and treatment.